DAX Slightly Up; Teladoc Reports Mixed Q2 Results Amid Market Trends
The DAX index closed at 18,479.00 with a 0.23% increase, while gold prices dipped slightly. In significant news, Teladoc Health reported a revenue of $642.4 million for Q2 2024, a 2% decrease year-over-year, alongside a net loss of $837.7 million. Newly appointed CEO Chuck Divita emphasized the need for improved execution and addressing challenges in the BetterHelp segment.
Teladoc (NYSE:TDOC) Misses Q4 Sales Targets, Stock Drops 13.2%
Teladoc Health (NYSE:TDOC) disappoints in Q4 FY2023 with 3.6% revenue growth, falling short of analyst estimates. The stock drops 13.2% as next quarter’s revenue guidance also misses expectations. With a market capitalization of $3.48 billion, the telemedicine platform faces questions about its future sales growth.